Table TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2009 or most recent year available [see all tables in this series...]

Part (v) New inpatient clients, age distribution by primary drug (%)

Substance	<15	15–19	20–24	25–29	30–34	35–39	40–44	45+	Mean age	Age known (base)	Age not known
Opioids	0.1	5.8	20.7	29.3	19.8	11.8	6.9	5.7	30.5	3911	7
Cocaine	0.1	4.3	20.9	25.6	18.2	13.2	10.7	7.0	31.5	703	2
Stimulants	0.5	19.9	29.8	21.2	14.6	4.2	3.7	6.0	27.0	1124	5
Hypnotics and sedatives	0.2	4.4	8.5	9.5	10.9	8.1	13.5	44.8	42.9	495	5
Hallucinogens	0.0	11.8	26.5	35.3	17.6	8.8	0.0	0.0	26.8	34	0
Volatile substances	5.9	52.0	14.4	14.9	8.9	2.5	0.0	1.5	21.7	202	0
Cannabis	1.4	24.8	27.5	18.4	12.6	6.2	4.0	5.0	26.5	1815	7
Other substances	0.9	7.9	16.1	14.5	10.3	9.7	8.2	32.4	38.0	330	0
Total	0.6	12.6	22.3	23.6	16.3	9.2	6.4	8.8	30.0	8614	26

Notes:

 The countries supplying data are: 

 AT; BE; BG; HR; CY; CZ; DK; FI; FR; DE; GR; HU; IE; NL; PL; RO; SK; SE; TR; UK.   

 The number of treatment clients in each country is listed in Table TDI-7. 

 See also Table TDI-104 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page. 

Sources:

 Reitox national reports 2010 — Table TDI outpatient and inpatient treatment centres. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)